Fig. 6From: DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathwayThe mechanism of chemoresistance to DNR in AML cells with DNMT3A-R882H mutationBack to article page